Oregon Public Employees Retirement Fund’s Acorda Therapeutics ACOR Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-132	Closed	-$15K	–	1610
2020 Q1	$15K	Hold	132	–	–	﹤0.01%	1581
2019 Q4	$32K	Hold	132	–	–	﹤0.01%	1579
2019 Q3	$46K	Buy	132 +2	+2%	+$1.09K	﹤0.01%	1635
2019 Q2	$120K	Buy	130 +3	+2%	+$3.69K	﹤0.01%	1609
2019 Q1	$203K	Buy	127 +2	+2%	+$3.6K	﹤0.01%	1516
2018 Q4	$234K	Buy	+125	New	+$272K	﹤0.01%	1478

Other funds holding ACOR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oregon Public Employees Retirement Fund's ACOR Position: Q2 2020 in Review

Oregon Public Employees Retirement Fund sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 132 shares — an estimated $15K sold.

Oregon Public Employees Retirement Fund first reported a position in ACOR in Q4 2018 and held it in 6 quarters. The position peaked at $234K in Q4 2018. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

Oregon Public Employees Retirement Fund reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 132 Acorda Therapeutics shares in Q2 2020, an estimated $15K.
Oregon Public Employees Retirement Fund first reported a position in Acorda Therapeutics in Q4 2018 and held it in 6 quarters.
Oregon Public Employees Retirement Fund's Acorda Therapeutics position peaked at $234K in Q4 2018.
79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2020, filed 21 Jul 2020.